Krause GC, Lima KG, Dias HB, da Silva EFG, Haute GV, Basso BS, et al
By working with a healthcare provider, patients can determine if this combination might help them reach their weight loss goals in a safe, controlled way
New Triple-Action Drug Retatrutide Shows Powerful Blood Sugar and Weight-Loss Benefits in Type 2 Diabetes Trial A promising new diabetes drug may significantly change the way type 2 diabetes is treated, offering substantial improvements in both blood sugar control and weight loss, according to findings from a major phase 3 clinical trial presented at the American Diabetes Association (ADA) Scientific Sessions and published in The Lancet
Good accuracy for doses between 10 and 50 units
Common reactions may include redness or swelling at the injection site, mild headaches, or temporary water retention